PT
Menu
Search
Sections
Home
News
Analysis
Features
Comment & Opinion
Projects
Data Insights
Sectors
Clinical Trials
Drug Manufacturers
Therapy Area
Cardiovascular
Central Nervous System
Immunology
Infectious Disease
Oncology
Respiratory
Pricing and Market Access
Themes
Artificial Intelligence
Corporate Governance
Cloud
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Events
Reports
Premium Insights
Excellence Awards
Magazine
Newsletters
GlobalData
About us
Advertise With Us
Contact Us
Our Marketing Solutions
GlobalData Reports
Visit GlobalData
From Our Partners
Transforming MedTech and Pharma using Software as a Medical Device (SaMD)
Accelerating Biopharmaceutical Innovation
Precision medicine and digital health innovation for disease diagnosis, care and treatment
Enabling process intensification in biopharma manufacturing
Specialty drug launch strategy and operations
The next chapter of clinical trial services
Future Pharma Services
Putting quality first in the pharma supply chain
Enabling better biopharmaceutical manufacturing
Pharmaceutical Grade Silicone Manufacturer
Maximising molecule potential
News
Analysis
Sections
Features
Comment & Opinion
Projects
Data Insights
Latest
Small-cap companies lead the oncology pipeline by programmes in development
Generics expected to improve access for patients with idiopathic pulmonary fibrosis
Alvotech’s AVT05 in Phase III rheumatoid arthritis study, as the sole candidate
Sectors
Sections
Clinical Trials
Drug Manufacturers
Therapy Area
Pricing and Market Access
Latest
Deka Biosciences secures $20m to advance product pipeline
Fabre-Kramer gains FDA approval for major depressive disorder therapy
FAYTEC
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Latest
Generative AI-focused biotech startup Evozyne raises $81m
FAYTEC
Ono and Adimab partner to develop oncology antibody drugs
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
Signal: Eli Lilly’s $176.5m Teva patent infringement loss overturned in US
Signal: AbbVie ends multi-million dollar cancer drug deal with I-Mab
Signal: CMR Surgical Raises $165m to continue development of surgical robot
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Latest
Leading providers of product inspection, testing and detection equipment and services
Mobile health strategies: Should you build or partner for success?
The competitive edge: Unlocking the full potential of autoinjectors through comprehensive in-house manufacturing
Events
Reports
Premium Insights
Newsletters
PT
All articles by Cameron Lockwood
Cameron Lockwood
Analyst Comment
Variations on an IRP theme: How payers are repurposing pricing policies for new categories of medicines
Analyst Comment
Taking the pulse of international reference pricing
Analyst Comment
Population health outcomes of American patients under different drug access conditions
Analyst Comment
2018 ISPOR Europe research on IRP
Analyst Comment
IRP rumblings: An eclipse of traditional market access strategy?
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.
Sign up
Analyst Comment
IRP is dead, long live IRP
Analyst Comment
Pharmaceutical pricing reform efforts in California: Poking the bear in the Grizzly State
Analyst Comment
The Access to Medicine Index 2016: Highlighting the role for tiered pricing
Analyst Comment
20 kilobases closer: A course correction for molecular diagnostics in Germany
Analyst Comment
Launch in the time of cost containment: How are European countries positioned to fund emerging breakthroughs in oncology?
View more
Most Popular
Buntanetap tartrate by Annovis Bio for Alzheimer’s Disease: Likelihood of Approval
MHRA grants authorisation for GSK’s endometrial cancer treatment
Sanofi and Janssen to develop vaccine candidate for E coli
